Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Creative Medical Technology | CELZ | Apr 17, 2025 | 1.97 | -0.51 |
Creative Realities | CREX | Apr 17, 2025 | 1.36 | +0.74 |
Credicorp | BAP | Apr 17, 2025 | 185.13 | -0.03 |
Credit Acceptance | CACC | Apr 17, 2025 | 472.19 | -2.07 |
Credit Enhanced Corts Trust Aon Capital A | KTN | Apr 17, 2025 | 26.54 | +0.22 |
Credit Suisse Ag | GLDI | Apr 17, 2025 | 165.74 | +0.03 |
Credit Suisse Ag | SLVO | Apr 17, 2025 | 78.99 | +0.23 |
Credit Suisse Asset Management Income Fund | CIK | Apr 17, 2025 | 2.70 | +0.37 |
Credit Suisse Gold Shares Covered Calls ETN | USOI | Apr 17, 2025 | 56.32 | +1.61 |
Credit Suisse High Yield Bond Fund | DHY | Apr 17, 2025 | 1.97 | 0.00 |
Credo Technology | CRDO | Apr 17, 2025 | 36.63 | -2.89 |
Crescent Capital BDC | CCAP | Apr 17, 2025 | 15.50 | +2.18 |
Crescent Energy | CRGY | Apr 17, 2025 | 8.38 | +3.08 |
Cresud A ADR | CRESY | Apr 17, 2025 | 12.39 | +3.60 |
Crexendo | CXDO | Apr 17, 2025 | 4.45 | -0.89 |
CRH | CRH | Apr 17, 2025 | 84.75 | -0.32 |
Cricut A | CRCT | Apr 17, 2025 | 4.12 | +0.37 |
Crinetics Pharmaceuticals | CRNX | Apr 17, 2025 | 30.42 | +2.84 |
CRISPR Therapeutics | CRSP | Apr 17, 2025 | 37.77 | -0.03 |
Criteo ADR | CRTO | Apr 17, 2025 | 29.90 | +2.40 |
Critical Metals | CRML | Apr 17, 2025 | 2.49 | +10.67 |
Crocs | CROX | Apr 17, 2025 | 90.72 | +2.31 |
Cronos Group | CRON | Apr 17, 2025 | 1.77 | 0.00 |
Cross Country Healthcare | CCRN | Apr 17, 2025 | 14.26 | -0.07 |
Cross Timbers Royalty Royalty Trust | CRT | Apr 17, 2025 | 10.32 | -4.88 |
CrossAmerica Partners LP Unit | CAPL | Apr 17, 2025 | 23.03 | 0.00 |
CrowdStrike A | CRWD | Apr 17, 2025 | 375.62 | -1.11 |
Crown Castle | CCI | Apr 17, 2025 | 103.59 | +2.31 |
Crown Crafts | CRWS | Apr 17, 2025 | 2.86 | -0.35 |
Crown Holdings | CCK | Apr 17, 2025 | 85.14 | +1.13 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.